The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
115747235 11574723 5 F 201501 20160819 20150930 20160824 PER US-PFIZER INC-2015293777 PFIZER 56.00 YR F Y 74.00000 KG 20160824 MD US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
115747235 11574723 1 PS LYRICA PREGABALIN 1 150 MG, 2X/DAY N46086 21446 150 MG CAPSULE, HARD BID
115747235 11574723 2 SS LYRICA PREGABALIN 1 150 MG, 2X/DAY 21446 150 MG CAPSULE, HARD BID
115747235 11574723 3 SS LYRICA PREGABALIN 1 150 MG, 2X/DAY 21446 150 MG CAPSULE, HARD BID
115747235 11574723 4 SS LYRICA PREGABALIN 1 Oral 150 MG, 2X/DAY 21446 150 MG CAPSULE, HARD BID
115747235 11574723 5 SS LYRICA PREGABALIN 1 Oral 150 MG, 2X/DAY 21446 150 MG CAPSULE, HARD BID
115747235 11574723 6 C NEXIUM ESOMEPRAZOLE MAGNESIUM 1 Oral 40 MG, DAILY 0 40 MG MODIFIED-RELEASE CAPSULE, HARD
115747235 11574723 7 C METFORMIN HCL METFORMIN HYDROCHLORIDE 1 Oral 1000 MG, 1X/DAY 0 1000 MG TABLET QD
115747235 11574723 8 C OXYCODONE OXYCODONE 1 UNK 0
115747235 11574723 9 C VOLTAREN DICLOFENAC SODIUM 1 600 MG, 3X/DAY 0 600 MG TID
115747235 11574723 10 C GABAPENTIN. GABAPENTIN 1 Oral 600 MG, 3X/DAY 0 600 MG TABLET TID
115747235 11574723 11 C WELCHOL COLESEVELAM HYDROCHLORIDE 1 Oral 625 MG, 1X/DAY 0 625 MG TABLET QD
115747235 11574723 12 C CYANOCOBALAMIN. CYANOCOBALAMIN 1 1000 UG/ML, MONTHLY 0 INJECTION /month
115747235 11574723 13 C CYANOCOBALAMIN. CYANOCOBALAMIN 1 1000 UG/ML, MONTHLY 0 INJECTION /month
115747235 11574723 14 C CYANOCOBALAMIN. CYANOCOBALAMIN 1 Sublingual 2500 UG, DAILY 0 2500 UG TABLET
115747235 11574723 15 C ERGOCALCIFEROL. ERGOCALCIFEROL 1 Oral 50000 IU, WEEKLY (50000UNIT CAPSULE, 1 ORAL) 0 50000 IU CAPSULE /wk
115747235 11574723 16 C DICLOFENAC SODIUM. DICLOFENAC SODIUM 1 Oral 75 MG, 2X/DAY 0 75 MG TABLET BID
115747235 11574723 17 C CYMBALTA DULOXETINE HYDROCHLORIDE 1 Oral 60 MG, DAILY 0 60 MG CAPSULE
115747235 11574723 18 C PREDNISONE. PREDNISONE 1 Oral 10 MG, 1X/DAY 0 10 MG TABLET QD
115747235 11574723 19 C PREDNISONE. PREDNISONE 1 Oral 20 MG, 1X/DAY 0 20 MG TABLET QD
115747235 11574723 20 C IPRATROPIUM BROMIDE. IPRATROPIUM BROMIDE 1 UNK, AS NEEDED ((0.02% SOLUTION, 1 (ONE) INHALATION EVERY FOUR HOURS) 0
115747235 11574723 21 C ALBUTEROL SULFATE. ALBUTEROL SULFATE 1 UNK, AS NEEDED ((1.25MG/3 ML NEBULIZED SOLN, 1 (ONE) NEBULIZED SOLN INHALATION EVERY FOUR HOURS) 0 INHALATION VAPOUR, SOLUTION
115747235 11574723 22 C FISH OIL FISH OIL 1 Oral 1000 MG, 2X/DAY 0 1000 MG CAPSULE BID
115747235 11574723 23 C VALIUM DIAZEPAM 1 Oral 10 MG, AS NEEDED (FOUR TIMES DAILY) 0 10 MG TABLET

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
115747235 11574723 1 Fibromyalgia
115747235 11574723 6 Dyspepsia
115747235 11574723 11 Blood cholesterol abnormal
115747235 11574723 12 Vitamin supplementation
115747235 11574723 15 Vitamin D deficiency

Outcome of event

no results found

Reactions reported

Event ID CASEID DRUG REC ACT PT
115747235 11574723 Arthralgia
115747235 11574723 Back pain
115747235 11574723 Drug ineffective
115747235 11574723 Gait disturbance
115747235 11574723 Hyperaesthesia
115747235 11574723 Intentional product misuse
115747235 11574723 Muscle spasms
115747235 11574723 Musculoskeletal stiffness
115747235 11574723 Neck pain
115747235 11574723 Pain
115747235 11574723 Swelling

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
115747235 11574723 1 201501 0
115747235 11574723 2 2015 0
115747235 11574723 3 20151016 0
115747235 11574723 4 20150923 0
115747235 11574723 5 20150112 0
115747235 11574723 6 20150923 0
115747235 11574723 7 20150112 0
115747235 11574723 10 20150112 0
115747235 11574723 11 20150611 0
115747235 11574723 12 20150629 0
115747235 11574723 13 20151009 0
115747235 11574723 14 20150513 0
115747235 11574723 15 20150112 0
115747235 11574723 16 20150112 0
115747235 11574723 17 20150112 0
115747235 11574723 18 20141031 0
115747235 11574723 19 20150711 0
115747235 11574723 20 20150112 0
115747235 11574723 21 20150112 0
115747235 11574723 22 20150812 0
115747235 11574723 23 20150910 0